ArticleBritish journal of cancer2026

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.

T Gelardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.